Global Clinical Trials Software Market 2023
The report covers market size and growth, segmentation, competitive landscape, trends and strategies for global clinical trials software market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
The market is segmented based on various factors, including deployment, delivery, feature, end-user, and geography.
Deployment: on-enterprises, on-site
Delivery: web-based, SaaS, on-premises
Feature: EDC, eCOA/ePRO, eConsent
End user: CROs, bio-pharmaceutical companies, medical device manufacturers, others
Segmentation by Geography
North America US, Canada
Europe Germany, France, UK, Italy, Spain
APAC - China, Japan, India, South Korea, Australia
Latin America Brazil, Mexico, Argentina
Middle East & Africa South Africa, Saudi Arabia, Turkey, UAE
The clinical trial software market is divided into on-enterprises and on-site segments. In 2022, on-enterprises held the dominant position, accounting for 78.6% of the market. This is due to the increasing adoption of technology in biopharmaceutical companies and the usage of clinical trial management systems. On-site deployment offers advantages to contracting research organizations, sponsors, and academic and government institutes. Biopharmaceutical companies with their own IT infrastructure find it easier to handle CTMS solutions, reducing costs and timelines.
Web-based delivery was the dominant segment in 2022, accounting for 44.5% of the market share. Major biopharmaceuticals prefer web-based delivery for seamless data management, analysis, medical writing, and regulatory submission. It enables quick reviews and efficient data collection from participants through internet platforms, reducing errors and confusion. The increasing competitiveness in the biopharma and contract research industries drives the demand for software. Web-based delivery provides faster delivery and is associated with the acceptance of Software-as-a-Service (SaaS) in CTMS.
The global clinical trials software market is further segmented into EDC, eCOA/ePRO, and eConsent. EDC, also known as eCRF, is vital for collecting and analyzing patient data. The increasing demand for participant data and the use of EDC contribute to significant market growth, with a share of 46.6% in 2022.
CROs accounted for 45.7% of the market share in 2022. They experience high demand for medical research from biopharmaceutical companies, medical device manufacturers, and other authorities. Intense competition, high investments, and low success rates of clinical trials drive the demand for CROs.
North America has the largest market share, with 34.3% in 2022. This is due to the presence of key market players, a high number of biopharmaceutical companies, and significant research and development expenditure in the region.
The global clinical trial software market is highly competitive due to collaboration, cloud-based platforms, and new solutions. Regional companies in Europe, APAC, and North America are investing in advanced software products, posing a threat to global players. This creates growth opportunities for existing and emerging players. Key companies profiled include Advarra, Inc., ArisGlobal LLC, Axiom Real-Time Metrics Inc., BSI Business Systems Integration AG, Ciwit B.V. (Castor), Clario, Inc., ClinCapture , Inc., Dassault Systemes SE, Datatrak International, Inc. (Fountayn LLC), Datatrial Limited, Dotmatics Limited (Statsols), Florence Healthcare, Inc., Fortress Medical Systems, LLC, IBM Corporation, IQVIA Holdings, Inc., Labcorp Drug Development Inc., Medrio, Inc., Oracle Corporation, PAREXEL International Corporation, Reify Health, Inc., Veeva Systems Inc., among others.
Scope of the Report
To analyze and forecast the market size of the global clinical trials software market.
To classify and forecast the global clinical trials software market based on deployment, delivery, feature, end user, geography.
To identify drivers and challenges for the global clinical trials software market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global clinical trials software market.
To identify and analyze the profile of leading players operating in the global clinical trials software market.
Why Choose This Report
Gain a reliable outlook of the global clinical trials software market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Advarra Inc., ArisGlobal LLC, Axiom Real-Time Metrics Inc., BSI Business Systems Integration AG, Ciwit B.V. (Castor), Clario Inc., ClinCapture Inc., Dassault Systemes SE, Datatrak International Inc. (Fountayn LLC), Datatrial Limited, Dotmatics Limited (Statsols), Florence Healthcare Inc., Fortress Medical Systems LLC, IBM Corporation, IQVIA Holdings Inc., Labcorp Drug Development Inc., Medrio Inc., Oracle Corporation, PAREXEL International Corporation, Reify Health Inc., Veeva Systems Inc.
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
PART 5. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY DEPLOYMENT
PART 6. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY DELIVERY
PART 7. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY FEATURE
PART 8. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY END USER
8.2 Bio-pharmaceutical companies
8.3 Medical device manufacturers
PART 9. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY GEOGRAPHY
9.1 North America
9.4 Latin America
9.5 Middle East & Africa
PART 10. COMPANY PROFILES
10.1 Advarra, Inc.
10.2 ArisGlobal LLC
10.3 Axiom Real-Time Metrics Inc.
10.4 BSI Business Systems Integration AG
10.5 Ciwit B.V. (Castor)
10.6 Clario, Inc.
10.7 ClinCapture , Inc.
10.8 Dassault Systemes SE
10.9 Datatrak International, Inc. (Fountayn LLC)
10.10 Datatrial Limited
10.11 Dotmatics Limited (Statsols)
10.12 Florence Healthcare, Inc.
10.13 Fortress Medical Systems, LLC
10.14 IBM Corporation
10.15 IQVIA Holdings, Inc.
10.16 Labcorp Drug Development Inc.
10.17 Medrio, Inc.
10.18 Oracle Corporation
10.19 PAREXEL International Corporation
10.20 Reify Health, Inc.
10.21 Veeva Systems Inc.
2023-2028 Global Virology and Bacteriology Database: US, Europe, Japan--100 Tests, Supplier Shares, Test Volume and Sales Segment ForecastsThis database from provides the 2023 supplier shares, the 2023-2028 volume and salesView Report
2023-2028 Global Virology, Bacteriology, Parasitology and Mycology Testing Market in the US, Europe and Japan--2023 Supplier Shares by Test, 2023-2028 Centralized and POC Volume and Sales Forecasts for 100 Respiratory,View Report
2023-2027 Global Clinical Chemistry Analyzers and Reagent Market--Supplier Shares, Volume and Sales Segment Forecasts for 55 Tests in the US, Europe, Japan--Emerging Opportunities, Growth Strategies, Latest Technologies and Instrumentation PipelineView Report
2023 Global Clinical Chemistry Market: Supplier Shares in the US, Europe, and Japan--Competitive Analysis of Leading and Emerging Market Players This new report provides clinical chemistry market shares in France,View Report
Fill The Form For Sample Request